INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
45 hedge funds and large institutions have $4.23M invested in Infinity Pharmaceuticals, Inc. in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
45
Holders Change
-8
Holders Change %
-15.09%
% of All Funds
0.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
15
Closed
10
Calls
$25K
Puts
$4K
Net Calls
+$21K
Net Calls Change
+$7K
Top Buyers
| 1 |
Mariner
Overland Park,
Kansas
|
+$252K |
| 2 |
CC
Carlson Capital
Dallas,
Texas
|
+$63.2K |
| 3 |
Renaissance Technologies
New York
|
+$25.8K |
| 4 |
EWM
Evercore Wealth Management
New York
|
+$15.2K |
| 5 |
WIM
Wittenberg Investment Management
Carlisle,
Massachusetts
|
+$12K |
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$62.9K |
| 2 |
VF
Virtu Financial
New York
|
-$28.8K |
| 3 |
Millennium Management
New York
|
-$25.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20.6K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$11.1K |
